Axsome Therapeutics Inc (AXSM) — Capital Reinvestment Ratio

Latest as of September 2025: 0.06x

Axsome Therapeutics Inc (AXSM) has a Capital Reinvestment Ratio of 0.06x as of September 2025, meaning it reinvests 0% of its operating cash flow ($1.05 Million) in capital expenditures ($58.00K). See how leveraged is Axsome Therapeutics Inc's balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.06x
Capex / Operating Cash Flow

Operating Cash Flow

$1.05 Million
USD

Capital Expenditures

$58.00K
USD

Data as of

Sep 2025
Most recent filing

Annual Capital Reinvestment Ratio for Axsome Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Axsome Therapeutics Inc from None to None. For live market cap and broader valuation context, see how much is Axsome Therapeutics Inc worth.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow